DaVita
DVA
#1896
Rank
HK$79.80 B
Marketcap
HK$1,194
Share price
-1.33%
Change (1 day)
0.32%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$78.92

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$79.29. In 2024 the company made an earnings per share (EPS) of HK$86.42 an increase over its 2023 EPS that were of HK$59.63.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$78.92-8.68%
2024HK$86.4244.94%
2023HK$59.6327.26%
2022HK$46.85-35.56%
2021HK$72.7144.1%
2020HK$50.4619.7%
2019HK$42.15540.48%
2018HK$6.58-76.07%
2017HK$27.50-19.31%
2016HK$34.08242.52%
2015HK$9.95-62.87%
2014HK$26.8013.43%
2013HK$23.628.45%
2012HK$21.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$183.89 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$82.50 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$115.18 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.88-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA